Top compounds associated with response to CTSV


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan FIMM pan-cancer AAC 0.15 0.2
mRNA BMS-754807 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.054 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.058 0.2
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.042 0.2
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.053 0.2
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.054 0.2
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.052 0.2
mRNA bendamustine CTRPv2 pan-cancer AAC -0.056 0.2
Download CSV